Goldline Pharmaceutical
add_icon

Goldline Pharmaceutical

41.00
+0.86
(2.14%)
Market Cap
39.32 Cr
PE Ratio
-
Volume
78,000.00
Day High - Low
41.00 - 40.14
52W High-Low
60.00 - 33.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
39.32 Cr
EPS
5.97
PE Ratio
-
PB Ratio
1.60
Book Value
25.05
EBITDA
6.90
Dividend Yield
0.00 %
Industry
-
Sector
-
Return on Equity
28.89
Debt to Equity
0.82
Forecast For
Actual

Company News

View All News
Caret
neutral
Goldline Pharmaceutical Limited has announced its 22nd Annual General Meeting for August 29, 2026. Shareholders can participate via remote e-voting through Bigshare Services from August 25 to August 28, 2026.
neutral
Goldline Pharmaceutical Ltd has appointed M/s. Avinash Gandhewar & Associates as Secretarial Auditor for FY2025-26. The firm will conduct the audit for the financial year ending March 31, 2026.
positive
Swapan Khandelwal bought 60,000 shares, increasing holding to 29.27%.
View more
Growth Rate
Revenue Growth
11.03 %
Net Income Growth
46.43 %
Cash Flow Change
-11.64 %
ROE
5.55 %
ROCE
3.95 %
EBITDA Margin (Avg.)
7.02 %

Yearly Financial Results

Annual Financials
2023
2024
2025
2026
Revenue
20
24
28
31
Expenses
18
19
22
24
EBITDA
2
4
6
7
Operating Profit %
11 %
18 %
21 %
22 %
Depreciation
0
0
0
0
Interest
2
2
2
1
Profit Before Tax
0
3
4
5
Tax
0
1
1
1
Net Profit
0
2
3
4
EPS in ₹
0.43
3.01
4.11
5.97

Balance Sheet

Balance Sheet
2023
2024
2025
2026
Total Assets
19
23
26
29
Fixed Assets
3
3
3
3
Current Assets
17
20
23
26
Capital Work in Progress
0
0
0
0
Investments
0
0
0
0
Other Assets
17
20
23
26
Total Equity & Liabilities
19
23
26
29
Current Liabilities
9
10
12
12
Non Current Liabilities
5
5
4
3
Total Equity
6
8
10
14
Reserve & Surplus
2
4
2
6
Share Capital
4
4
9
9

Cash Flow

Cash Flow
2023
2024
2025
2026
Net Cash Flow
-0
1
0
-1
Investing Activities
-1
-1
0
-0
Operating Activities
2
3
3
3
Financing Activities
-1
-1
-3
-3

Share Holding

% Holding
Sept 2025
May 2026
Promoter
79.71 %
79.71 %
FIIs
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
Government
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
Others
20.29 %
20.29 %
No of Share Holders
20
20

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2026 39.00 40.97
09 Jun 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Jun 2026 46.03 44.20

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2026
Intimation Of Record Date For Remote E-VotingAug 06, 2026
Intimation Of Book Closure Shall Remain Closed From Sunday 23Rd August 2026 To Saturday 29Th August 2026 (Both Days Inclusive) For Taking Record Of The Members Of The Company For The Purpose Of 22Nd (Twenty Second) Annual General Meeting Of The Company ScAug 06, 2026
Reg. 34 (1) Annual Report.Aug 06, 2026
Intimation Of Notice Of 22Nd Annual General Meeting Of Goldline Pharmaceutical Limited Will Be Held On Saturday 29Th August 2026 At 4:00 P.M. At Hotel Airport Centre Point 131/1 Adjacent To Airport Wardha Road Somalwada Nagpur Maharashtra 440025Aug 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jul 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 20, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJul 14, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AJun 24, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 24, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 24, 2026
Disclosure Under Regulation 29 (2) Of Securities And Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulations 2011Jun 23, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJun 09, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 09Th June 2026Jun 09, 2026
Outcome Of Board Meeting Held Today I.E. 09Th June 2026Jun 09, 2026
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 To Be Held On Tuesday June 09 2026.Jun 02, 2026
Closure of Trading WindowMay 27, 2026
Listing of Equity Shares of Goldline Pharmaceutical LtdMay 19, 2026

Technical Indicators

RSI(14)
Neutral
50.78
ATR(14)
Less Volatile
1.72
STOCH(9,6)
Neutral
40.06
STOCH RSI(14)
Neutral
69.45
MACD(12,26)
Bullish
0.14
ADX(14)
Weak Trend
13.30
UO(9)
Bearish
52.93
ROC(12)
Downtrend And Accelerating
-2.45
WillR(14)
Neutral
-64.19